Quest Diagnostics Inc <DGX.N>: Mizuho Raises Target Price to $260 From $235
DGX•Related News
Canada's CN Railway beats Q2 revenue estimates, lifts 2026 outlook
CNI•
BiomX subsidiary Zorronet partners with Samura to expand in Europe
PHGE•
Dyadic Announces Continued Listing On The Nasdaq Capital Market
DYAI•
Verisign, Inc <VRSN.O>: Wedbush Raises Target Price to $324 from $318
VRSN•
Building evidence private credit redemptions past peak retail angst, TD Cowen says
BX•